ARQT Q4 2020 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$166,000

Operating Income

-$34M

Net Income

-$34M

EPS (Diluted)

$-0.79

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$33M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$298M

Total Liabilities

$28M

Stockholders' Equity

$271M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$166,000	-$60,000	-176.7%
Operating Income	-$34M	-$13M	-162.2%
Net Income	-$34M	-$13M	-170.9%